EMA – 15th industry stakeholder platform on research and development support held the 4 December 2025: publication of the presentation materials
This was the fifteenth in a series of regular meetings between regulators and representatives of industry stakeholder organisations. It addressed all areas of evidence generation along the medicine’s life-cycle and related to development support activities, such as scientific advice and qualification, as well as specifics for paediatric and orphan medicines.
This meeting focused on:
- strengthening the delivery of scientific advice to efficiently support development programmes including agile scientific advice and broad scientific advice affecting multiple products
- modernising the Qualification of Novel Methodologies framework
- translating the experience from the piloting of the new PRIME features into optimised operations
- feedback from the HMA/EMA multi-stakeholder workshop on reporting and qualification of mechanistic models for regulatory assessment
- proposal for the pilot of a voluntary data submission framework to establish potential alternatives to animal testing in line with the 3Rs principles
- progressing the support to paediatric developments
- identification of product-specific bioequivalence guidelines
- gocus group to explore opportunities for the use of Real-World Data (RWD) and the generation of Real-World Evidence (RWE)
- strengthening support to evidence generation for combination (MD/IVD) Products
Find the presentation materials of the event on the EMA Website.
OpenEdition vous propose de citer ce billet de la manière suivante :
vroby (18 février 2026). EMA – 15th industry stakeholder platform on research and development support held the 4 December 2025: publication of the presentation materials. ELSIBI. Consulté le 6 novembre 2026 à l’adresse https://doi.org/10.58079/15pvo





